pinocembrin has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, GH; Gao, M; Tan, CB; Xu, B; Zhang, WC; Zhu, SY | 1 |
| Du, GH; Gao, M; Liu, R; Yang, ZH | 1 |
2 other study(ies) available for pinocembrin and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Pinocembrin protects the neurovascular unit by reducing inflammation and extracellular proteolysis in MCAO rats.
Topics: Animals; Apoptosis; Brain; Brain Ischemia; Flavanones; Infarction, Middle Cerebral Artery; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Rats; RNA, Messenger; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2010 |
Pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro.
Topics: Analysis of Variance; Animals; Apoptosis; Cells, Cultured; Cerebral Cortex; Flavanones; Infarction, Middle Cerebral Artery; Male; Neurons; Neuroprotective Agents; Nitric Oxide; Organ Culture Techniques; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Statistics, Nonparametric | 2008 |